Physician profile
Gregory Tiesi
NPI 1942464003
$1,511.62
in general payments reported to CMS, 2019-2025
21 companies · $399 in 2025
The $399 reported for 2025 was more than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $173 · 2020: $70.85 · 2022: $14.91 · 2023: $531 · 2024: $323 · 2025: $399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,252.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $231.08 | 2023-2025 | Neuwave, Echelon Flex, Vistaseal |
| Becton, Dickinson and Company | $163.94 | 2024 | Phasix Mesh |
| Intera Oncology, INC | $161.45 | 2024-2025 | Intera |
| Sanara Medtech INC. | $136.52 | 2025 | Biasurge |
| Boston Scientific Corporation | $126.62 | 2023 | Exalt Model D |
| Davol INC. | $87.91 | 2019 | |
| Angiodynamics, INC. | $85.00 | 2019 | |
| Medical Device Business Services, INC. | $83.25 | 2023 | Neuwave |
| Stryker Corporation | $70.85 | 2020 | |
| Galvanize Therapeutics, INC | $55.48 | 2025 | Aliya System |
| Dilon Technologies, INC. | $48.97 | 2024-2025 | Hemoblast Bellows |
| Karl Storz Endoscopy-America | $47.21 | 2023 | Image 1 S |
| Medtronic, INC. | $37.67 | 2024 | Synchromedii |
| Digestive Care, INC. | $37.19 | 2023 | Pertzye |
| Hologic Sales and Service, LLC | $23.00 | 2024 | Coolseal Generator |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tempus Ai, INC | $22.21 | 2025 | Xt Cdx |
| Corcept Therapeutics | $22.15 | 2023 | Korlym |
| Solventum Corporation | $21.26 | 2025 | Prevena |
| Abbott Laboratories | $18.31 | 2023 | Freestyle Libre 3 |
| Abbvie INC. | $16.64 | 2025 | |
| Ibsa Pharma INC. | $14.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Tiesi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.